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Background: Although ageing is strongly associated with cognitive decline, a wide range of cognitive ability is
observed in older populations with varying rates of change across different cognitive domains.
Methods: Cognitive function was measured as part of the third health examination of the European Prospective
Investigation of Cancer in Norfolk (EPIC-Norfolk 3) between 2006 and 2011 (including measures from the pilot
phase from 2004 to 2006). This was done using a battery consisting of seven previously validated cognitive function
tests assessing both global function and specific domains. The battery included a shortened version of the
Extended Mental State Exam (SF-EMSE); letter cancellation task; Hopkins Verbal Learning Test (HVLT); Cambridge
Neuropsychological Test Automated Battery Paired Associates Learning Test (CANTAB-PAL); Visual Sensitivity Test
(VST); Shortened version of the National Adult Reading Test (Short-NART) and a task to test for prospective memory.
We report the distribution of cognitive function in different cognitive domains by age and sex and compare the
utility of a number of assessment tests in a general population of older men and women.
Results: Cognitive test data were available for 8585 men and women taking part in EPIC-Norfolk 3. Increasing age
was generally associated with declining mean cognitive function, but there was a wide range observed within each
age group as well as variability across different cognitive domains. Some sex differences were also observed.
Conclusion: Descriptive data are presented for this general population sample of older men and women. There is a
wide range of cognitive performance seen in this population. Though average performance declines with age,
there is large individual variability across different cognitive domains. These variations may provide insights into the
determinants of cognitive function in later life.
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Ageing is generally associated with memory impairment
and cognitive decline, however, this decline is not inevit-
able [1] and not all domains of cognitive function are
equally affected with age [2]. A broad range of cognitive
capability is observed in the older population [3] as well
as substantial inter-individual heterogeneity in rates of* Correspondence: Shabina.hayat@phpc.cam.ac.uk
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unless otherwise stated.decline [4]. The range encompasses high cognitive func-
tioning even in the very old [5], mild cognitive impair-
ment (MCI), through to dementia at the other end of
the spectrum.
Mild Cognitive Impairment (MCI) is described as the
transitional state between normal cognitive ageing and de-
mentia [6], with detectable impairment to memory or cog-
nitive abilities when compared to healthy controls, but not
to the extent as seen in individuals suffering with mild de-
mentia [7]. The amnestic form of MCI has been shown to
be predictive of dementia [7-10], however, the conversionhis is an Open Access article distributed under the terms of the Creative
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minority of individuals with MCI progress to dementia
within clinically relevant time frames. As a result of the
heterogeneity in both the aetiology and outcome of this
condition, MCI is still an area of major debate, with no
consensus on its classification [11]. Reliable identification
of those individuals with MCI who remain stable com-
pared to those who decline would maximise efficacy of
potential treatments and preventive interventions around
this transitional stage [12]. To determine the factors that
contribute to this variability in not just the rates of decline
in MCI, but also in the different cognitive abilities, will
help to improve the understanding of the natural progres-
sion of decline in an ageing population.
Substantial data already exist on dementia and cognitive
impairment, mainly in the older population, from using a
wide range of instruments, each with merits and limita-
tions that assess different aspects or stages of cognition.
Episodic memory deficits have been shown in a number
of studies to be associated with the strongest and most
persistent risk of cognitive decline [13,14] and are the
most common and earliest complaints in MCI [15]. How-
ever deficits in other cognitive domains can also occur,
some early on, including attention, executive functioning,
prospective memory, semantic memory, verbal ability,
visuospatial skills, attention and processing speed [16-19].
There is a need for assessments to cover a broad range of
ability and domains, and have an optimal balance between
sensitivity and specificity with high positive predictive
value in the settings in which they will be applied.
There are no cures for dementia, but there are some ad-
vances in the development of drugs [20] that are known
to improve symptoms, or temporarily slow down disease
progression in early and middle stages of the disease. To
exploit the potential benefits of any such treatment and to
facilitate decision making for future plans, it is important
to identify early indicators of decline. However, before we
are able to advise guidelines and policies on health, we
need to gain better insight into the ageing process in the
general population and the range of functions in both do-
main specific and global cognition.
The primary aim of this study was to obtain data from
a general population of men and women without overt
cognitive impairment using a comprehensive cognitive
test battery assessing a range of function including
memory (retrospective and prospective), executive func-
tion, attention, calculation, registration, language, praxis,
abstract thinking, processing and new learning. The sec-
ondary aim was to explore the comparability of the dif-
ferent tests and their use in a community setting. We
focused on producing a standardised protocol for test
administration and scoring, thus minimising variation,
differences in interpretation and reducing subjectivity.
Details of the standardisation methods are given here.Methods
The European Prospective Investigation of Cancer
(EPIC) is a 10-country collaboration studying diet and
disease with half a million participants [21,22], of which
EPIC-Norfolk is one of the UK centres. Detailed descrip-
tions of recruitment and study methods at baseline have
been reported elsewhere [23]. Briefly, participants were
recruited at baseline through registers in thirty five gen-
eral practices in Norfolk between 1993 and 1997. Gen-
eral practice registers approximate population based
registers as virtually all the population are registered
through the UK National Health Service. Participants
who consented at baseline were re-invited for a health
examination at subsequent phases. The data presented
here is from the third health examination (3HC or
EPIC-Norfolk 3) conducted between 2006 and 2011 (in-
cluding data from the pilot phase between 2004 and
2006) [24]. The characteristics of the participants taking
part in EPIC-Norfolk 3 are given in Table 1. Attrition
rates and characteristics of these returning participants
have been described previously where the cohort was
shown to represent a diverse population [24]. This study
was approved by the Norfolk Local Research Ethics Com-
mittee (05/Q0101/191) and East Norfolk and Waveney
NHS Research Governance Committee (2005EC07L). Par-
ticipants gave signed informed consent at both baseline
and then subsequently at the 3HC to cover new measures
that were not present in previous health examinations.
The Cognition battery used in EPIC-Norfolk 3 (EPIC-
COG) comprised of a number of validated tests that have all
been described previously. These included a shortened
version of the Extended Mental State Exam [25] (SF-EMSE),
letter cancellation task [26] as used in the Medical Research
Council Cognitive Function and Ageing Study (MRC CFAS)
[27], Hopkins Verbal Learning Test (HVLT) [28],
Cambridge Neuropsychological Test Automated Battery
Paired Associates Learning Test (CANTAB-PAL) [29-31],
Visual Sensitivity Test (VST) to assess visual impairment
deficits contributing to cognitive impairment [32] Short Na-
tional Adult Reading Test (Short-NART) [33] and a test for
prospective memory (also as described in MRC CFAS) [34].
These tests are briefly described here with further information
given in the Additional file 1. The tests were selected with the
intention to cover an array of cognitive domains and a range
of difficulty. Modifications were made to shorten some of the
tests to allow for use in an epidemiological setting. The bat-
tery was part of a broader health examination that lasted ap-
proximately 2–3 hours depending on the participant.
Cognitive tests
Short Form Extended Mental State Exam (SF-EMSE)
The Extended Mental State Exam (EMSE) [25] extends
the widely used Mini Mental State Exam (MMSE) [35], a
test known for its limitations [36,37], in particular in
Table 1 Characteristics of the men and women in the
EPIC-Norfolk 3 cohort
Characteristic Men
(N = 3861)
Women
(N = 4762)
Mean (SD)
Age 69.4 ( 8.1) 68.1 (8.0)
Mental activity score
(from Questionnaire)
21.1 (4.7) 23.2 (4.7)
Frequency% (N)
Education level
Left school with no formal qualification 22.2 (857) 29.7 (1412)
Left school with at least O level or
equivalent
77.8 (3003) 70.3 (3349)
Social class
I-III Non-manual 64.5 (2472) 67.2 (3165)
III Manual-V 35.5 (1362) 32.8 (1544)
Smoking status
Current 4.2 (159) 4.5 (213)
Former 57.8 (2198) 36.4 (1711)
Never 38.0 (1446) 59.1 (2774)
Physical activity
Inactive 37.4 (1422) 37.2 (1748)
Moderately-inactive 25.1 (954) 32.2 (1513)
Moderately-active 18.7 (713) 16.9 (796)
Active 18.8 (714) 13.6 (641)
Employment and social activity
Retired from main occupation 75.9 (2855) 78.8 (3562)
Active in social groups 59.5 (2264) 68.5 (3219)
SD = Standard Deviation, Frequency N = Number.
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consists of 47 items in total including items from the
Cambridge Mental Disorders of the Elderly Examination
(CAMDEX) interview schedule [38] as well as items rec-
ommended in the report from the MRC Alzheimer’s
Disease Workshop in 1987 [39]. Here, we used a modi-
fied shorter version consisting of 26 selected items asses-
sing functioning at the higher end of the ability range.
Short Form Mini Mental State Exam (SF-MMSE)
The SF-MMSE predicts the full-scale MMSE score by as-
suming an almost perfect performance on the excluded
items in a highly functioning population [40]. The ‘full
derived’ MMSE score (SF-MMSE Score +14) was used in
the analysis here to allow the comparison of the other com-
ponents of the battery using the SF-MMSE scores as a vali-
dated and recognised standard.
Attention and visual search (Letter Cancellation)
This task involved a visual search of a set of random let-
ters with the aim of crossing out as many of the 72possible target letters (P and W) within one minute. The
outcome measure was ‘Accuracy Score’ (number of cor-
rectly identified target letters minus all potential target
letters missed).
Hopkins Verbal Learning Test (HVLT)
Participants were asked to memorise words presented
on a computer screen. At the end of the presentation
participants were asked to recall the words. The list was
shown a further two times. Correctly recalled words
were recorded and the combined score of all three trials
(Total HVLT Score) was used as the outcome measure.
Cambridge Neuropsychological Test Automated Battery
Paired Associates Learning Test (CANTAB-PAL)
The Paired Associates Learning Test (CANTAB-PAL),
tests episodic memory and new learning and has shown
to be a sensitive tool as a determinant of memory deficit
in the early stages of dementia [30,31,41,42]. Six white
boxes (and then eight at the final stage) were presented
on a touch screen, opening sequentially to display 1,2,3,6
and then 8 abstract visual patterns. Immediately after
the final test pattern was displayed, one of the patterns
was displayed in the middle of the screen and the par-
ticipant was required to touch the box where that pat-
tern was located on the screen. The task consisted of
eight stages and up to ten presentations after which the
task terminated. The outcome measure used here was
the ‘first trial memory score’ (FTMS), the number of pat-
terns correctly associated to their locations in the first
attempt summed across the stages completed.
Visual sensitivity test (reaction time)
This test consisted of two parts: Firstly, a triangle ap-
peared randomly on the screen and the participant was
required to press the space bar on the computer as soon
as the triangle was seen. In the second part, a triangle
formed from a screen full of moving dots and again the
participant had to press the space bar as soon as the tri-
angle was seen. The outcome measure of reaction time
(in milliseconds) was recorded and stored automatically
under the participant’s unique study number.
The National Adult Reading Test (NART)
The National Adult Reading Test (NART) [43] shown to
correlate with pre-morbid intelligence and general cog-
nitive ability [44,45], is accepted in both clinical and re-
search settings. It is known to have some limitations,
particularly in the less educated [46]. The participant
was required to correctly pronounce the list of NART
words presented on a computer screen. In this study, the
short NART protocol [33,47] was used. The outcome
measure was ‘NART Error Score’, where a higher score
indicates lower performance.
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This is a test for the memory for future intentions, previ-
ously suggested to be sensitive to early stages of cognitive
decline [34,48]. Participants were asked to remember to
carry out an explicit instruction at a specified point later
in the appointment. Participants were defined as being
‘successful’ if they carried out at least one correct action
without having to be prompted.
Covariates
Data on covariates were obtained from a self-
administered questionnaire. Smoking status, mental
activities, employment status and hobbies were ob-
tained from responses from the health questionnaire
completed near the time of EPIC-Norfolk 3. The men-
tal activity score was calculated by assigning 1 point
for an individual who reported doing a particular ac-
tivity once a year or less up to 5 points if they did the
activity every day. In total there were seven activities
(listening to the radio, reading the newspaper, reading
magazines, reading books, playing games such as cards or
chess, crosswords and puzzles). The minimum score
possible was 7 and the maximum was 35. Those with
missing data were excluded from the analysis.
Education level was obtained from baseline question-
naire and was coded into two categories: The first con-
sisted of those leaving school with no formal qualification
(less than O level or equivalent). The second category
consisted of those leaving school with at least some quali-
fication. The qualification group combined those attaining
O-level or equivalent (completing school to the age of 15),
A-level or equivalent (completing schooling to the age of
17 years) and those obtaining a degree or equivalent.
Missing data and extreme outliers
If a test was abandoned or the participant refused to
continue, the participant was scored on what had been
completed and the data included in the analysis. Reasons
for refusal were recorded to differentiate those partici-
pants who refused or failed to complete as a result of a
technical fault or ran out of time, from those who re-
fused because they expressed anxiety or difficulty with
the task. Those who refused prior to starting a test or
those who said no to a test component were assigned as
missing data. Any participant identification number that
could not be accurately assigned to a known individual
was also removed from the final analysis as were any im-
plausible values described below.
Statistics
The outcome measures of six of the test components were
continuous. The prospective memory variable measure
was dichotomised into ‘successful’ and ‘unsuccessful’. The
descriptive data (using the original untransformed scoresof the continuous variables) are presented as medians and
inter-quartile ranges as the cognitive scores in EPIC-COG
were not normally distributed (although means and stand-
ard deviations are also presented in the Additional files 2
and 3: Table S1-S2). For the SF-EMSE Items, letter
cancellation (Accuracy Score), HVLT, and CANTAB-PAL
(FTMS), a higher score indicated better performance. The
outcome measure for VST (reaction time) and for the
NART (Short NART-Error Score), a higher score indicated
poorer performance. Cross sectional data are presented by
age and sex and by age, sex and MMSE Category. To give
further details of the data, a graphical representation of the
scores using a range of percentiles (1st, 10th, 25th, 50th,
75th, 90th and 99th) by age group and sex are also pro-
vided. Statistical analysis was performed using SPSS ver-
sion 21.0 (IBM Corp., Armonk, NY, USA).
Results
Of the 8623 participants attending EPIC-Norfolk 3, 45%
(n = 3861) were men and 55% (n = 4762) were women.
Cognitive data were collected on 8585 individuals, with
over 90% completing or attempting six or all seven of
the tests in the battery. The CANTAB-PAL and VST
had slightly lower completion rate (at 86.5% and 83% re-
spectively), partly due to a technical computer failure,
resulting in loss of data on 150 participants. Table 2
summarises the cognitive domains covered by each of
the tests used in this study and the number of partici-
pants completing each test component.
Men and women were equally likely to complete all
seven components, with 6011 (69.7%) participants
attempting all seven test components of EPIC-COG
and only 850 participants (less than 10%) of those tak-
ing part attempting or completing five components or
fewer. Those completing all seven components were
slightly younger (mean age 68.8 compared to 70.9 years
in men and 67.4 compared to 69.8 years in women),
and were more likely to be either in paid employment
or actively taking part in regular social networks when
compared those who did not complete all the tests.
More men had left school with qualifications than
women (77.8% compared to 70.3%), although more
women participated in regular social activities (68.5%
for women compared to 59.5% for men). Women also
reported more mental stimulating activities in their
leisure time (with mean mental activity score of 23.2 in
women as compared to 21.1 for men).
Distributions for cognitive function (by each test com-
ponent and stratified by sex) are presented in Figure 1.
The EMSE distribution had a negative skew but did not
have the same strong ceiling effect as the SF-MMSE
scores in this cohort (distribution not shown), with 2298
(27%) of participants scoring the maximum SF- MMSE
score of 29 as compared to only 2.4% (n = 200) scoring
Table 2 Summary of test components of the EPIC-COG battery and the number of participants who successfully
attempting all or part of each component
Cognitive test Cognitive domain Outcome measure*
(Maximum possible test score)
Number of participants
attempted/completed
test component
Short form-extended mental
state exam (SF-EMSE)
Global measure of cognition from MMSE to asses
domains for retrospective memory (immediate and
delayed), attention and calculation, registration, verbal
registration, language (object naming/sentence),
visual and constructional skills, praxis. Added items for
Memory (extension on retrospective memory), praxis,
verbal fluency (animal naming), language (writing to
dictation) and abstract thinking.
SF-EMSE Score (37) 98% (8483)
Letter cancellation task Executive function - (covering visual search, attention,
mental and processing speed)
Accurately identified target letters
in one minute (72)
97.5% (8410)
Hopkins verbal learning
test (HVLT)
Recognition/learning and episodic memory Total HVLT Score - Total of
correctly identified target
words over 3 trials (36)
93.7% (8081)
CANTAB®-paired associate
learning (CANTAB-PAL)
Episodic memory and new learning/Visuospatial First Trial Memory Score (26) 86.5% (7281)
Visual sensitivity test (VST) Visuospatial (magnocellular pathway) Reaction Time in milliseconds 83% (7144)
National adult reading
test (NART)
Proxy Measure of IQ - Pre-morbid Intelligence Short NART Error Score - Using the
short-NART algorithm (50)
94.1% (8112)
Time and event based task Prospective memory Success vs Failure 97% (8403)
*Frequencies for only one outcome measure given in this summary table.
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cancellation (PW Accuracy) and HVLT Total Score were
both approximately normal distributed, as was the distri-
bution for FTMS (other than a peak at score 0, which
suggests that a high proportion of participants were un-
able to achieve a correct response immediately). The
data for reaction time of the VST were highly positively
skewed (as a result of a few extreme, but genuine slow
responders).
For the short NART, there was a peak at the error
score of 24, followed by alternating peaks and troughs in
data giving a ‘comb’ distribution. This pattern in the dis-
tribution is as a result of the short NART algorithm (as
described in the Additional file 1). The peaks in the dis-
tribution can be attributed to those assigned an error
score by the algorithm, artificially inflating the scores at
these points. The greatest peak (and the starting point of
this comb effect of the data) was seen to occur at the
cut-off point of score of 20 (giving a full NART error of
24), which was the point where participants with this
score or lower, did not continue with the second half of
the test.
The median scores of each of the test components
were plotted with age in men and women as shown in
Figure 2a-2g. The data presented here are cross-
sectional values showing the association of scores with
age group. The graphical presentations in Figure 2 indi-
cate that median scores decline with age. The proportion
of participants successfully completing the prospective
memory task lowers with increased age group. In the caseof the VST (Figure 2f), the median reaction time increases
with age group. The NART error score showed an in-
crease with age initially, remains steady then a slight re-
duction in the oldest group (Figure 2g). In almost all tests,
women generally performed better than men.
The data were further characterised by calculating per-
centile scores plotted by age group (Figure 3). In this fig-
ure, lower scores are seen across increasing age group.
Higher percentiles of cognitive scores remain reason-
ably stable across age groups, but the spread and vari-
ation in scores becoming greater across each age group,
with the lowest percentile having markedly lower per-
formance. The variation in scores was least for the SF-
EMSE compared to the other tests in the battery. For
reaction time and short NART error score, the 99th
percentile indicated the poorest performers. The short
NART error score exhibited widest variation across age
and even some improvement in scores in the oldest age
groups.
Comparability of test components with the widely
accepted MMSE
The measures from each test component were com-
pared to the MMSE, which is widely used in both re-
search and clinical settings. The accepted cut off score
of less than or equal to 23 as indicating presence of
cognitive impairment has evolved from research find-
ings [37] although higher cut-offs have been used
[49,50]. In this high functioning cohort, there were very
few individuals with a score of ≤23; therefore the cut
Figure 1 Distribution of scores (of continuous variables) in men
and women in EPIC-Norfolk 3.
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10th percentile score of 24. We used our modified form
of the MMSE (i.e. SF-MMSE) and created three cat-
egories based on the distribution of SF-MMSE scores in
the study population. The first category was defined
as ≤ 24), the third category was defined at the highest
SF-MMSE scores (28 and 29) and the middle category
was created using the remaining scores of 25–27.
Tables 3 and 4 shows the distribution of all the tests in
EPIC-COG across the three SF-MMSE categories in
men and women respectively. The general trends for all
the test components were similar with the scores of the
continuous test variables improving across SF-MMSE
categories. For the prospective memory test, the propor-
tion of participants successfully completing the task also
increased across the three SF-MMSE categories. Again,
scores in women were slightly higher than men. There
was still a range of performance seen across all three SF-
MMSE categories.
The top performing 2298 participants who performed
perfectly on the SF-MMSE (achieving a maximum pos-
sible score of 29), also included participants who were
amongst the poor performers (with scores in the bottom
10th percentile) for the other components. These find-
ings were still valid for the top 25% and for the top 10%
of the SF-EMSE performers (Table 5), although the
numbers were increasingly lower than those seen with
the top SF-MMSE scores.
Spearman’s rank correlation coefficients were calcu-
lated (Table 6) to investigate the strength of relation-
ship between each of the tests used in EPIC-COG. The
correlations were moderate to weak for most tests with
HVLT having stronger associations with the other tests,
such as with SF-EMSE (r = 0.49) followed by FTMS
(r = 0.38) and short NART (r = −0.38). This inverse as-
sociation was as a result of the NART Error scale, with
larger number representing poor performance.
To illustrate the relationship of the tests further, the
distribution of the scores were plotted as contour plots
(Figure 4). The contours represent the strength of the
relationship between the scores of the test components.
The first plot in each row shows the outcome measure
variable of each individual test plotted against itself
depicting the perfect positively linear association. The
peak (white area) representing the region with greatest
density of scores, centres at different points for each
test pair combination. There seemed to be some un-
defined spread for each test, however there was a sys-
tematic pattern seen in all the plots, with some of the
test pairs showing a better relationship than others.
The general direction of the plot and the peak of over-
lap of scores seem to appear in areas where one would
expect, however with most of the plots what is seen at
best is a moderate relationship between these tests.
Figure 2 Cognition performance with age in men and women. 2a-2d are cognition test scores where higher scores indicating better
performance and figures 2f and 2g are error scores where higher scores indicating poorer performance. Median values shown for the continuous
variables and for prospective memory (figures 2e) shown as percentage of the participants successfully completing task.
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Figure 3 Cross sectional percentile levels of scores by age group in EPIC-Norfolk men and women. A graphical presentation of percentile
scores plotted against age group (cross-sectional) showing performance from the highest to the lowest percentile scores in the six components
of the EPIC-COG battery with continuous scores.
Hayat et al. BMC Geriatrics 2014, 14:142 Page 8 of 16
http://www.biomedcentral.com/1471-2318/14/142
Hayat et al. BMC Geriatrics 2014, 14:142 Page 9 of 16
http://www.biomedcentral.com/1471-2318/14/142Discussion
In this cross-sectional study, we report on cognitive
function profiles across a range of domains using previ-
ously validated instruments in a general population of
men and women from mid to later life (age 48–92
years). We focused mainly on age related differences in
cognition measures, and found that, despite the EPIC-
COG being a relatively long battery, it was well tolerated
by this general study population.
Individuals can have impairment in one cognitive do-
main but perform well in another or a number of cogni-
tive deficits can occur concurrently. There is increasing
evidence of substantial variability in cognitive abilities
within individuals. Hilborn et al., (2009) termed this
variability in performance across different tasks within
an individual as ‘dispersion’. It is important to gain a
better understanding of the dispersion displayed by
healthy individuals in order to allow accurate clinical
judgment on unhealthy or abnormal dispersion [51].
Previous studies have shown that a variety of cognitive
deficits are associated with preclinical stages of different
types of dementias and that decline can occur in a num-
ber of cognitive domains, even before any of the clinical
criteria of early stages of cognitive decline are met [52-54].
Our findings are consistent with previous studies that have
shown variability and dispersion across different cognitive
domains [51,55] in older people. Further investigation is
necessary to confirm whether the differences observed
across the domains provide any meaningful indicators of
cognitive performance over time.
The frequency distribution and data from the pilot
(where the full NART was used for 300 participants) in-
dicate that the short NART equation does not hold so
well in this heterogeneous ageing population as it did in
the homogenous sample of elderly women living in a
rural setting that it was initially tested on. The aim of
the short- NART was to lessen participant load and anx-
iety, however in an assessment such as the one in this
study; participants were as likely to be anxious for any of
the other components. The pilot data show that partici-
pants who obtained a score of 20 (n = 82) for the first
half of NART obtained a mean score of 7.9 (SD = 3.7)
for the second half, which is better than what the algo-
rithm predicts. Therefore, we would recommend that
despite the appeal of the short NART, this protocol is
not appropriate for a higher functioning population
where few individuals have poor reading skills. If there
are concerns about causing distress, then we would sug-
gest lowering the cut-off to at least 17 rather than having
the cut-off at 20.
Prevalence of severe cognitive impairment is relatively
low in our cohort but as with previous studies [56,57],
we also found age to be inversely associated with the
complete range of cognitive function being tested withthe exception of NART, where there did not seem to be
any strong association between the short NART score
and age. This confirms previous findings that NART is a
good measure of pre-morbidity [44,45] and that age has
little or no effect on NART performance in the absence
of early dementia [58].
We observed some differences in abilities across gen-
der and age categories. These may have arisen because
of age and sex differences in education status. Although
we have not investigated education in detail here, there
is good heterogeneity of individuals leaving school with
and without qualifications in all age groups analysed.
We also observed a trend not noted in other studies, of
women performing better than men in all the test com-
ponents across all age groups, even though more men
than women reported leaving school with some qualifi-
cation suggesting that educational status would not ex-
plain the sex differences seen in this cohort. However,
women reported to be more socially active and to be
doing more mentally stimulating activities in their spare
time, which have been linked to better cognitive per-
formance at older age. The effects of education, social
networks and mental activity will be the focus of further
research.
Although the test scores generally decline across age
groups with the widest variation seen in the oldest age
group, there is still a range of capability from poor to
high performance in each age band, with some partici-
pants from the oldest age group outperforming their
younger counterparts. Percentile scores from our cross-
sectional data (Figure 3) show that the greatest decline
in all test components is seen in poor performers across
all the age groups. This graphical presentation can be
used to compare scores or estimate age and sex adjusted
scores across the different domains investigated here. In-
dividuals scoring below the 25th percentile could be
considered as cognitively impaired for that domain and
require further investigation.
The MMSE’s lack of ability to assess individual do-
mains and its poor sensitivity to mild cognitive impair-
ments are frequently cited limitations [59,60] This is
because most healthy individuals can successfully answer
most of the test items. Even though more demanding
tests are available [25,36,60,61], the MMSE still remains
the most widely used and cited test of global cognition.
To allow comparability with other studies, we included
the SF-MMSE to provide a baseline for future studies
and as a means of comparing the psychometric qualities
and utility of the other tests used in the battery. The
MMSE, being a global measure of cognition contains
items that test the same domains of memory function as
the other components of EPIC-COG. As expected, a
positive trend was seen in all the tests with increased
SF-MMSE score category, however, a range of scores
Table 3 Distribution of cognition test component scores by MMSE cut off- score in men
Test MMSE score ≤ 24 MSSE score 25-27 MMSE score 28-29
Frequency
(n)
Mean (SD) Median (IQR) Range Frequency
(n)
Mean (SD) Median (IQR) Range Frequency
(n)
Median (SD) Median (IQR) Range
SF-ESME 240 25.2 (5.4) 27 (24, 28) 0, 32 1489 31.3 (2.2) 32 (30, 32) 17, 35 2073 34.2 (1.6) 34 (33, 35) 26, 37
P-W accuracy score 222 6.5 (7.9) 8 (3, 12) −28, 20 1474 10.5 (5.9) 11 (7, 14) −23, 31 2064 12.8 (5.6) 13 (10, 17) −31, 34
HVLT 209 19.1 (5.9) 19 (15, 23) 0, 33 1391 22.4 (5.3) 23 (19, 26) 5, 35 1980 25.5 (4.9) 26 (22, 29) 7, 36
FTMS 195 11.9 (4.9) 13 (9, 15) 0, 23 1258 14.3 (4.6) 15 (12, 18) 0, 26 1794 16.2 (4.2) 17 (14, 19) 0, 26
VST (ms) 190 237 (733) 2263 (2063, 2509) 1239, 10489 1222 2310 (427) 2260 (2056, 2506) 567, 7148 1777 2253 (382) 2214 (2025, 2442) 1232, 7838
NART error score 200 25. 2 (11. 1) 26 (17, 33) 2, 50 1394 20.1 (10.4) 19 (12, 26) 0, 49 1985 15.6 (9.4) 14 (8, 22) 0, 49
Prospective memory
(% at least one
action correct)
217 55% 1470 73% 2063 84%
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Table 4 Distribution of cognition test component scores by MMSE cut off- score in women
Test MMSE score ≤ 24 MSSE score 25-27 MMSE score 28-29
Frequency
(n)
Mean (SD) Median (IQR) Range Frequency
(n)
Mean (SD) Median (IQR) Range Frequency
(n)
Median (SD) Median (IQR) Range
SF-ESME 390 26. 8 (3.8) 28 (26. 29) 4, 32 1718 31.5 (2.0) 32 (30, 33) 20, 35 2573 34.4 (1.5) 35 (34, 35) 24, 37
P-W accuracy score 375 9.3 (6.4) 10 (613) −16, 35 1710 12.3 (5.8) 12 (9, 16) −28, 32 2565 14.3 (5.8) 14 (11, 18) −26, 54
HVLT 352 21.1 (6.0) 22 (17, 25) 5, 36 1612 24.6 (5.3) 25 (21, 29) 0, 36 2467 27.9 (4.5) 29 (25, 31) 10, 36
FTMS 325 13.2 (4.5) 13 (11, 17) 0, 24 1433 14.8 (4.6) 15 (12, 18) 0, 26 2212 16. 6 (4.1) 17 (14, 19) 0, 26
VST (ms) 302 2393 (825) 2294 (2076, 2538) 459, 12869 1408 2259 (447) 2216 (2004, 2466) 1054, 7973 2167 2184 (374) 2156 (1965, 2374) 710, 8695
NART error score 358 24. 3 (10.4) 24 (16, 31) 2, 50 1616 18.6 (9.4) 18 (11, 26) 0, 47 2487 14.3 (8.4) 13 (8, 20) 0, 45
Prospective memory
(% at least one
action correct)
379 64% 1707 79% 2567 90%
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Table 5 Distribution of scores in participants with near perfect SF-MMSE and SF-EMSE scores
(A) Top MMSE score of 29 (B) Top 25% EMSE score (≥35) (C) Top 10% EMSE score (≥36)
Men Women Men Women Men Women
N* Frequency
% (N)
N* Frequency
% (N)
N* Frequency
% (N)
N* Frequency
% (N)
N* Frequency
% (N)
N* Frequency
% (N)
P-W accuracy score
(10th percentile < = 5)
1006 8.2 (82) 1286 5.3 (68) 1034 5.5 (57) 1336 4.2 (56) 418 2.9 (12) 569 3.1 (18)
HVLT (10th percentile < =18) 962 6.7 (64) 1238 2.4 (30) 998 4.6 (46) 1285 1.1 (14) 404 1.5 (6) 568 0.5 (3)
FTMS (10th percentile < = 10) 870 6.2 (54) 1122 4.2 (47) 895 5.1 (46) 1149 3.6 (41) 360 5.3 (19) 514 2.5 (13)
VST (10th percentile > =2702 ms) 874 7.8 (68) 1100 5.4 (59) 904 7.1 (64) 1131 4.6 (52) 366 5.2 (19) 509 4.5 (23)
Short NART error score
(10th percentile > =31)
964 5.9 (57) 1252 2.6 (33) 1006 4.0 (40) 1308 1.7 (22) 409 1.7 (7) 577 1.2 (7)
Participants achieving (A) Perfect MMSE Score of 29 (B) Top 25% SF-EMSE score and (C) Top 10% SF-EMSE score and scoring in the bottom 10th percentile of the
other cognition tests.
N*: Total Number of Participants with both test scores available.
N: Number of participants in the bottom 10th percentile.
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categories.
On further investigation of participants obtaining the
maximum score of 29 on the SF-MMSE, we found in
the range of 6-8% of men and 2-5% of women also
scored in the bottom 10th percentile of the other tests
(Table 5). On examining those individuals who obtained
the top 25% and further in the top 10% SF-EMSE scores,
there were still participants in poorest performers (10th
percentile) of the other tests, although the figures were
reduced. Those scoring in the bottom 10th percentile
tended to be older than those with scores above the 10th
percentile for all the tests apart from the Short NART
The number of participants scoring the maximum pos-
sible on the SF-EMSE was small (n = 200). None of these
individuals scored in the bottom 10th percentile of the
other tests other than one person who scored in the low-
est 10th percentile for the NART. We show that obtaining
a perfect score on the MMSE does not indicate absence of
impairment and this confirms previous findings for the
need to supplement the MMSE in cognitive testing [37],
particularly in a normal to high functioning population.
The limited reliability and validity of the MMSE in a
general population has been attributed to the restricted
range of MMSE. The EMSE has been shown to be sensi-
tive across a range of performance, to avoid the ceilingTable 6 Spearman’s correlation coefficient between the test c
SF-EMSE PW accuracy
PW-Accuracy 0.33
HVLT 0.49 0.33
FTMS 0.34 0.26
Prospective memory 0.26 0.19
VST −0.16 −0.17
NART −0.38 −0.21effect and that (even in its short form as it has been used
here), the EMSE provides extended coverage of cognitive
domains (extending on attention, memory, processing
and executive function). This report confirms previous
findings that the EMSE has advantages over the MMSE
particularly for testing individuals at the high end of the
performance range [25].
Spearman’s rank correlation (Table 6) show correla-
tions are moderate to weak for most tests with HVLT
having the strongest associations with other test compo-
nents especially with FTMS and NART. This is not sur-
prising, as HVLT, FTMS and NART assess similar
cognitive sub domains of memory and language, how-
ever the moderate degree of correlation is somewhat
counterintuitive as we would expect this to be higher.
The contour plots (Figure 4) depict the spread of scores
(and area of overlap) indicating that with some associ-
ation, there is also some non-systematic scatter of scores
suggesting that these tests may be assessing different as-
pects of cognitive function.
We have also addressed some practical and methodo-
logical issues with regards to minimising variability and
subjectivity that can be introduced at any part of admin-
istration, scoring or cleaning of the data. We have de-
scribed methods of standardisation in an epidemiological
setting to ensure accuracy and consistency. Having theseomponents of the EPIC-COG battery
HVLT FTMS Prospective memory VST
0.38
0.23 0.21
−0.17 −0.17 −0.09
−0.34 −0.21 −0.13 0.06
Figure 4 Contour plots to show relationship of data from EPIC-COG battery. The contours represent the strength of the relationship between
the scores of the test components. The first plot (on the left) in each row shows the outcome measure variable of each individual test plotted against
itself depicting the perfect positively linear association.
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important to allow comparability and potential harmon-
isation of data with other studies. The other advantage of
this study over previous studies is that it has been con-
ducted in a large well characterised cohort of men and
women with good representation from a very wide age
range, which has been a limiting factor in some previous
studies [27,62-64].
Limitations to the study
The main limitations of this study relate to all cohort stud-
ies, and that is of healthy volunteer bias and attrition as
highlighted previously [24]. However, although there is
likely to be some loss of the more cognitively impaired, the
oldest and frailest participants, there remains a wide range
of performance and health across the whole age span of
interest (from mid–life to over 90 years) represented inEPIC-Norfolk 3. The other limitation is that this is a cross-
sectional study and so age differences and between persons
effect can be observed but not within person differences or
age related changes for which longitudinal data is required.
Finally, and very importantly, we have not adjusted for the
potential effects of education which is a known strong pre-
dictor of cognitive function [65-67] and on the rates of de-
cline [68]. However, the purpose of this paper was not to
look at lifestyle factors in any detail, but to present the de-
scriptive data on this cohort. The effects of education and
other factors on cognitive performance across different do-
mains will be examined in future analysis.
Conclusion
Everyday activities in the real world are complex, requiring
independence, planning, organisation, sequencing and
judgement and have been shown to be a significant
Hayat et al. BMC Geriatrics 2014, 14:142 Page 14 of 16
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cognitive function in a range of domains such as executive
functions, planning, flexibility, abstract thinking, semantic
memory as well as episodic memory is vital. Also of con-
siderable importance is to accurately identify early decline
in individuals or those with MCI who are known to be at
increased risk of dementia, particularly Alzheimer’s dis-
ease (AD) compared to older people without any obvious
cognitive impairment.
Here we have used a comprehensive battery of accur-
ate and well tolerated tests to provide evidence of cogni-
tive function in a number of cognitive domains that have
previously been reported to be involved in much earlier
stages of decline. We have described how, even though
there is reduction in performance across age, there is
also a great deal of heterogeneity in older individuals.
Further work is needed to understand why cognitive
abilities vary so greatly across individuals and cognitive
domains and to investigate the more subtle changes in
cognition. We have also demonstrated that the EMSE
even in its short form provides a better description of
the cognitive abilities in a general functioning population
and that the short NART protocol is not suitable for a
heterogeneous higher functioning population. Finally,
careful consideration should be given to the purpose
for using a particular test (including whether the aim
is to obtain global or domain specific measure, time
availability and target population) when selecting an as-
sessment tool for cognitive function.
There is epidemiological evidence of associations be-
tween lifestyle factors (such as diet, smoking and exer-
cise) and risk of dementia [70]. The EPIC-Norfolk study
has over twenty years of lifestyle, biological and genetic
information, collected from mid to late in life. This study
is well placed not only to identify factors associated with
decline but also factors associated with maintaining abil-
ities in older age. With the data already collected and
further follow up data, we can investigate patterns of be-
haviours over time and predict how those behaviours
affect cognitive function.Additional files
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